Evaluation of Clinical, Immunological, Morphological, Molecular and Genetic Characteristics of Patients With Limb-girdle Muscular Dystrophy Type R2 (Type 2B) in the Russian Federation
Каталог · ЕАЭС
Клинические исследования и проекты
Artgen Biotech · найдено 5
5 исследований
Идёт
Здоровые добровольцы
Россия
DYSF-Observation (RUS) · Artgen Biotech
Завершено
Фаза II–III
Россия
Neovasculgen (Cambiogeneplasmid) · Artgen Biotech
Phase 3 Study of Efficiency, Safety and Portability of Gene Therapy Drug Neovasculgen (DNA Encoding the 165-amino-acid Isoform of Human Vascular Endothelial Growth Factor (pCMV - VEGF165) for Peripheral Arterial Disease Complex Treatment
Завершено
Россия
Neovasculgen · Artgen Biotech
Safety and Efficacy Study of Pl-vegf165 to Treat Diabetic Foot Syndrome
Завершено
Фаза IV
Россия
Neovasculgen® · Artgen Biotech
International Postmarketing Surveillance Study of Pl-VEGF165 Safety and Efficacy in 210 Patients With Peripheral Arterial Disease
Статус неизвестен
Фаза I–II
Россия
Neovasculgen · Artgen Biotech
Safety and Efficacy Study of Pl-vegf165 to Treat Secondary Raynaud's Phenomenon Caused by Systemic Scleroderma